Chugai Pharmaceutical Co. Ltd. (CHGCY)
OTC
Closed
Aug 24, 2026
Day's Range
21.7552 wk Range
20.27Profile - CHGCY - Chugai Pharmaceutical Co. Ltd.
Profile
Mic Code
PINX
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
5.10K
Chugai Pharmaceutical Co. Ltd. is a prominent player in the biotechnology and pharmaceutical industry, renowned for its commitment to innovative drug development and personalized healthcare solutions. The Tokyo-based company, founded in 1925, has established itself as a leader in the field of oncology, immunology, and other therapeutic areas, leveraging cutting-edge technology to develop breakthrough treatments and improve patient outcomes. Chugai is particularly known for its robust pipeline of novel drugs and its strategic partnership with Roche, a global healthcare leader, which has significantly expanded its reach and capabilities in global markets. The company's extensive research and development efforts focus on biologics and proprietary technologies to address unmet medical needs, making significant impacts in sectors like cancer treatment and autoimmune disorders. Furthermore, Chugai's integration of digital innovation in its operations underscores its role as a forward-thinking entity within the pharmaceutical landscape. As a key contributor to the healthcare industry, Chugai Pharmaceutical Co. Ltd. not only plays a critical role in advancing medical science but also supports the broader goal of enhancing health and quality of life worldwide.
Profile Details
Type
American Depositary Receipt
Ceo
Dr. Osamu Okuda
Address
Nihonbashi Mitsui Tower
City
Chuo
Zip
103-8324
Country
Japan
Phone
81 3 3281 6611
Cross Listings - CHGCY - Chugai Pharmaceutical Co. Ltd.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
